Beijing Dynaflow Lab Solutions: CSRC Requests Supplementary Materials on Equity Change Compliance and Background of Zhongluhangmiao Acquisition
NewTimeSpace News: The International Department of the CSRC has publicly disclosed supplementary material requirements for overseas issuance and listing filings for 24-28 August 2026, under which Beijing Dynaflow Lab Solutions Co., Ltd. is required to supplement multiple matters.
The requirements include: explaining the prices and pricing basis of historical capital increases and equity transfers, capital contribution compliance and historical nominee shareholdings, with conclusions on the legality of establishment and historical equity changes and the valid existence of the entity; explaining the pricing basis of new shareholders added within 12 months prior to the filing, the reasons for price differences versus contemporaneous capital increases, and the income tax paid by the transferors; explaining the fairness and standard operation of the employee shareholding plan and whether there are reserved or unissued interests; explaining the historical changes of principal businesses, cooperation with universities and research institutes, the background of the acquisition of Zhongluhangmiao, and whether the business involves areas restricted under foreign investment access; and confirming whether shares of shareholders participating in the "full circulation" are subject to pledges, freezes or other title defects.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- TH MEDICAL-B (02697.HK): Signs Sales Contract of Nearly RMB 100 Million for Puncture Surgical Navigation System
- HK shares ETFs Daily Report: Robotics and AI Lead HK ETFs! Hang Seng Biotech ETFs Plunge Over 3.7%, Biomedicine and Blockchain ETFs Collapse - 20260831
- Monthly Shanghai-Shenzhen Stock Connect ETF Average Return Statistics (by Fund Manager) (August 2026)
- Monthly Shanghai-Shenzhen Stock Connect ETF Return Statistics (August 2026)
- Shanghai-Shenzhen Stock Connect ETFs Daily Report: Satellite ETFs Surge Over 4%! STAR AI and Media ETFs Rally Broadly, Gold-Stock and Grain ETFs Slump - 20260831